Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
BIO KEY INTERNATIONAL INC reported fourth quarter ended December 31, 2023 results: net income $(4.1M), EPS $(5.54) per share.
- Period
- fourth quarter ended December 31, 2023
- Net income
- $(4.1M)
- EPS
- $(5.54) per share
- Result
- preliminary results
Exact text from the filing
Likewise, in Q4’23 BIO-key reduced its net loss more than 40% to $(4.1M), or $(5.54) per share, from $(6.7M), or $(14.58) per share in 2023.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
BIO KEY INTERNATIONAL INC reported year ended December 31, 2023 results: revenue $9.1M, net income $(6.2M), EPS $(11.45) per share.
- Period
- year ended December 31, 2023
- Revenue
- $9.1M
- Net income
- $(6.2M)
- EPS
- $(11.45) per share
- Result
- preliminary results
Exact text from the filing
Exhibit 99.1 Identity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10am ET Holmdel, NJ – April 1, 2024 – BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and
View on SEC.gov